Nuvation Bio Inc (NUVB)
1.9900 +0.2400 (+13.71%) 04/11/25 [NYSE]
1.9500 x 1,000 2.2500 x 100
Realtime by (Cboe BZX)
1.9500 x 1,000 2.2500 x 100
Realtime 2.0000 +0.0100 (+0.50%) 04/11/25
for Fri, Apr 11th, 2025
Results
download Want to compare other data? Select FieldsSymbol | NUVB | NRIX | PHVS | ||
Company | Nuvation Bio Inc | Nurix Therapeutics Inc | Pharvaris N.V. | ||
Price Information | |||||
Exchange | NYSE | NASDAQ | NASDAQ | ||
Open | 1.7900 | 8.86 | 11.90 | ||
High | 2.0300 | 9.15 | 12.19 | ||
Low | 1.7211 | 8.60 | 11.66 | ||
Last | 1.9900 | 9.14 | 12.00 | ||
Change | +0.2400 | +0.33 | +0.10 | ||
% Change | +13.71% | +3.75% | +0.84% | ||
Volume | 4,185,300 | 900,200 | 56,600 | ||
20-Day Average Volume | 2,988,820 | 1,230,100 | 30,380 | ||
Previous Close | 1.7500 | 8.81 | 11.90 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | Yes | Yes | No | ||
Technicals | |||||
20-Day Moving Average | 1.8480 | 11.61 | 14.63 | ||
20-Day Raw Stochastic | 71.43% | 14.98% | 8.72% | ||
20-Day Relative Strength | 50.59% | 29.73% | 29.70% | ||
Weighted Alpha | -41.68 | -65.88 | -51.80 | ||
Today's Opinion | 88% Sell | 100% Sell | 100% Sell | ||
Previous Opinion | 100% Sell | 100% Sell | 100% Sell | ||
Last Month's Opinion | 80% Sell | 100% Sell | 72% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | +19.88% since 04/04/25 | -5.68% since 04/04/25 | -15.97% since 04/04/25 | ||
Low | 1.5400 on 04/07/25 | 8.18 on 04/10/25 | 11.51 on 04/10/25 | ||
High | 2.0300 on 04/11/25 | 10.39 on 04/08/25 | 14.06 on 04/07/25 | ||
1-Month | |||||
%Chg | -13.10% since 03/11/25 | -34.24% since 03/11/25 | -25.23% since 03/11/25 | ||
Low | 1.5400 on 04/07/25 | 8.18 on 04/10/25 | 11.51 on 04/10/25 | ||
High | 2.4200 on 03/12/25 | 14.87 on 03/12/25 | 17.99 on 03/13/25 | ||
3-Month | |||||
%Chg | -28.42% since 01/10/25 | -49.89% since 01/10/25 | -32.58% since 01/10/25 | ||
Low | 1.5400 on 04/07/25 | 8.18 on 04/10/25 | 11.51 on 04/10/25 | ||
High | 2.8200 on 01/24/25 | 20.66 on 01/27/25 | 19.90 on 01/22/25 | ||
6-Month | |||||
%Chg | -12.33% since 10/11/24 | -61.32% since 10/11/24 | -39.18% since 10/11/24 | ||
Low | 1.5400 on 04/07/25 | 8.18 on 04/10/25 | 11.51 on 04/10/25 | ||
High | 3.4550 on 01/07/25 | 29.56 on 11/11/24 | 25.50 on 11/04/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 673,971 | 696,797 | 627,480 | ||
Shares Outstanding, K | 338,679 | 76,236 | 52,290 | ||
Annual Sales | 7,870,000 | 54,550,000 | 0 | ||
Annual Net Income | -567,940,000 | -193,570,000 | -109,180,000 | ||
Last Quarter Sales | 5,710,000 | 13,280,000 | 0 | ||
Last Quarter Net Income | -49,450,000 | -58,550,000 | -45,870,000 | ||
60-Month Beta | 1.47 | 2.23 | -2.84 | ||
Per-Share Information | |||||
Most Recent Earnings | -0.15 on 03/06/25 | -0.67 on 04/08/25 | -0.68 on 04/07/25 | ||
Latest Earnings Date | 05/13/25 | 04/09/25 | 05/14/25 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |